Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.040
+0.010 (0.97%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,637,667
Market Cap
3.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ARTL News
- 27 days ago - Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025 - GlobeNewsWire
- 7 weeks ago - Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex® - GlobeNewsWire
- 2 months ago - Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland - GlobeNewsWire
- 3 months ago - Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12 - GlobeNewsWire
- 4 months ago - Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia - GlobeNewsWire
- 5 months ago - Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit - GlobeNewsWire
- 5 months ago - Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium - GlobeNewsWire